Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works

An overlap invariant entropy measure of 3D medical image alignment

Studholme, C., Hill, D., & Hawkes, D. J. (1999) · Pattern Recognition · doi:10.1016/s0031-3203(98)00091-0 · Cited by 2,167 · see citing works

Global burden of depressive disorders in the year 2000

Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · see citing works

The neural basis of loss aversion in decision-making under risk

Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007) · Science · doi:10.1126/science.1134239 · Cited by 1,733 · see citing works

The therapeutic potential of monoamine oxidase inhibitors

Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,374 · see citing works

Three-Year Outcomes for Maintenance Therapies in Recurrent Depression

Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,294 · see citing works

MONOAMINE OXIDASE: From Genes to Behavior

Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,211 · see citing works

Distributed Neural Representation of Expected Value

Knutson, B., Taylor, J., Kaufman, M., Peterson, R., & Glover, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0642-05.2005 · Cited by 955 · see citing works

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · see citing works

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · see citing works

Multimodal Image Coregistration and Partitioning—A Unified Framework

Ashburner, J., & Friston, K. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 932 · see citing works

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861 · see citing works

Exact and approximate rebinning algorithms for 3-D PET data

Defrise, M., Kinahan, P. E., Townsend, D. W., Michel, C. J., Sibomana, M., & Newport, D. F. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563660 · Cited by 757 · see citing works

Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites

Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676 · see citing works

Neural mechanisms mediating optimism bias

Sharot, T., Riccardi, A. M., Raio, C. M., & Phelps, E. A. (2007) · Nature · doi:10.1038/nature06280 · Cited by 659 · see citing works

Elevated Monoamine Oxidase A Levels in the Brain: An Explanation for the Monoamine Imbalance of Major Depression

Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585 · see citing works

Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D ₂ Receptor Parameter Measurements in Ventral Striatum

Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · see citing works

Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [¹¹C]DASB Positron Emission Tomography Study

Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · see citing works

Incorporating Prior Knowledge into Image Registration

Ashburner, J., Neelin, P., Collins, D. L., Evans, A. C., & Friston, K. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0299 · Cited by 455 · see citing works

Cognitive Therapy and Pharmacotherapy for Depression

Simons, A. D. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010045006 · Cited by 440 · see citing works

Relapse of depression after rapid depletion of tryptophan

Smith, K., Fairburn, C. G., & Cowen, P. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07044-4 · Cited by 428 · see citing works

Brain monoamine oxidase A inhibition in cigarette smokers

Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., Shea, C. E., Alexoff, D. L., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423 · see citing works

Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter

Stockmeier, C. A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00050-5 · Cited by 357 · see citing works

Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging Study

Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V. S., Hussey, D. F., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 339 · see citing works

Unmasking Disease-Specific Cerebral Blood Flow Abnormalities: Mood Challenge in Patients With Remitted Unipolar Depression

Liotti, M., Mayberg, H. S., McGinnis, S., Brannan, S. L., & Jerabek, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1830 · Cited by 331 · see citing works

Mental Depression in Hypertensive Patients Treated for Long Periods with Large Doses of Reserpine

Freis, E. D. (1954) · New England Journal of Medicine · doi:10.1056/nejm195412162512504 · Cited by 322 · see citing works

Mitochondrial involvement in psychiatric disorders

Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A. F., Akil, H., Myers, R., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 303 · see citing works

Neural and Behavioral Responses to Tryptophan Depletion in UnmedicatedPatients With Remitted Major Depressive Disorder and Controls

Neumeister, A., Nugent, A. C., Waldeck, T., Geraci, M., Schwarz, M., Bonne, O., Bain, E. E., Luckenbaugh, D. A., Herscovitch, P., Charney, D. S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.765 · Cited by 273 · see citing works

Lower dopamine transporter binding potential in striatum during depression

Meyer, J. H., Krüger, S., Wilson, A. A., Christensen, B. K., Goulding, V. S., Schaffer, A., Minifie, C., Houle, S., Hussey, D., & Kennedy, S. H. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00052 · Cited by 269 · see citing works

Brain Serotonin Transporter Binding Potential Measured With Carbon11–Labeled DASB Positron Emission Tomography

Meyer, J. H., Houle, S., Sagrati, S., Carella, A., Hussey, D. F., Ginovart, N., Goulding, V. S., Kennedy, J. L., & Wilson, A. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1271 · Cited by 265 · see citing works

Dysfunctional Attitudes and 5-HT₂ Receptors During Depression and Self-Harm

Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264 · see citing works

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

Bel, N., & Artigas, F. (1993) · Synapse · doi:10.1002/syn.890150310 · Cited by 237 · see citing works

The Effect of Paroxetine on 5-HT_2A Receptors in Depression: An [¹⁸F]Setoperone PET Imaging Study

Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231 · see citing works

Elevated Brain Serotonin Turnover in Patients With Depression

Barton, D. A., Esler, M., Dawood, T., Lambert, É., Haikerwal, D., Brenchley, C., Socratous, F., Hastings, J. A., Guo, L. J., Wiesner, G., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.11 · Cited by 220 · see citing works

Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging

Watson, C. C., Newport, D. F., Casey, M., deKemp, R. A., Beanlands, R. S., & Schmand, M. J. (1997) · IEEE Transactions on Nuclear Science · doi:10.1109/23.554831 · Cited by 218 · see citing works

Increased 5-HT 2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [ 11 C]MDL 100,907

Bhagwagar, Z., Hinz, R., Taylor, M. J., Fancy, S., Cowen, P. J., & Grasby, P. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1580 · Cited by 214 · see citing works

Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy Subjects

Hasler, G., Fromm, S., Carlson, P. J., Luckenbaugh, D. A., Waldeck, T., Geraci, M., Roiser, J. P., Neumeister, A., Meyers, N., Charney, D. S., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.521 · Cited by 209 · see citing works

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

Biver, F., Wikler, D., Lotstra, F., Damhaut, P., Goldman, S., & Mendlewicz, J. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.171.5.444 · Cited by 197 · see citing works

An automated method for the extraction of regional data from PET images

Rusjan, P., Mamo, D. C., Ginovart, N., Hussey, D., Vitcu, I., Yasuno, F., Suhara, T., Houle, S., & Kapur, S. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.01.011 · Cited by 177 · see citing works

Brain Serotonin2 Receptors in Major Depression

Yatham, L. N., Liddle, P. F., Shiah, I., Scarrow, G., Lam, R. W. M., Adam, M. J., Zis, A. P., & Ruth, T. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.850 · Cited by 170 · see citing works

Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography

Mintun, M. A., Sheline, Y. I., Moerlein, S. M., Vlassenko, A. G., Huang, Y. H., & Snyder, A. Z. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.015 · Cited by 160 · see citing works

Elevated Putamen D ₂ Receptor Binding Potential in Major Depression With Motor Retardation: An [ ¹¹ C]Raclopride Positron Emission Tomography Study

Meyer, J. H., McNeely, H. E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N. P. L. G., Wilson, A. A., & Houle, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1594 · Cited by 160 · see citing works

A Psychometric Evaluation of the DSM-IV Personality Disorder Criteria

Blais, M. A., & Norman, D. K. (1997) · Journal of Personality Disorders · doi:10.1521/pedi.1997.11.2.168 · Cited by 137 · see citing works

Risk and Resilience Markers in Bipolar Disorder: Brain Responses to Emotional Challenge in Bipolar Patients and Their Healthy Siblings

Krüger, S., Alda, M., Young, L. T., Goldapple, K., Parikh, S., & Mayberg, H. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.257 · Cited by 126 · see citing works

Reproducibility of BOLD-based functional MRI obtained at 4 T

Tegeler, C., Strother, S. C., Anderson, J. R., & Kim, S. (1999) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(1999)7:4 · Cited by 121 · see citing works

Brain Biogenic Amine Depletion and Mood

Mendels, J. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760100019004 · Cited by 119 · see citing works

Transient Depressive Relapse Induced by Catecholamine Depletion

Berman, R., Narasimhan, M., Miller, H., Anand, A., Cappiello, A., Oren, D. A., Heninger, G. R., & Charney, D. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.395 · Cited by 118 · see citing works

Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors

Pinsonneault, J. K., Papp, A. C., & Sadée, W. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl192 · Cited by 114 · see citing works

Tryptophan depletion and depressive vulnerability

Moreno, F., Gelenberg, A. J., Heninger, G. R., Potter, R. L., McKnight, K., Allen, J. J. B., Phillips, A. P., & Delgado, P. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00095-5 · Cited by 111 · see citing works

Biochemistry and pharmacology of moclobemide, a prototype RIMA

Haefely, W. E., Burkard, W. P., Cesura, A. M., Kettler, R., Lorez, H. P., Martin, J. R., Richards, J. G., Scherschlicht, R., & Prada, M. D. (1992) · Psychopharmacology · doi:10.1007/bf02246225 · Cited by 110 · see citing works

Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients

Taylor, B. P., Bruder, G. E., Stewart, J. W., McGrath, P. J., Halperin, J., Ehrlichman, H., & Quitkin, F. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.73 · Cited by 109 · see citing works

Evaluating antidepressant therapies: remission as the optimal outcome.

Thase, M. E. (2003) · PubMed · Cited by 107 · see citing works

Constrained Fourier space method for compensation of missing data in emission computed tomography

Karp, J. S., Muehllehner, G., & Lewitt, R. M. (1988) · IEEE Transactions on Medical Imaging · doi:10.1109/42.3925 · Cited by 107 · see citing works

Positron Emission Tomography Quantification of [11C]-Harmine Binding to Monoamine Oxidase-A in the Human Brain

Ginovart, N., Meyer, J. H., Boovariwala, A., Hussey, D. F., Rabiner, E. A., Houle, S., & Wilson, A. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600197 · Cited by 102 · see citing works

Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes

Moreno, F., Heninger, G. R., McGahuey, C. A., & Delgado, P. L. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00893-3 · Cited by 82 · see citing works

11C-harmine as a tracer for monoamine oxidase a (MAO-A): In vitro and in vivo studies

Bergström, M., Westerberg, G., & Långström, B. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00013-9 · Cited by 75 · see citing works

In vivo regulation of the serotonin-2 receptor in rat brain

Stockmeier, C. A., & Kellar, K. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90003-2 · Cited by 73 · see citing works

Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum

Roth, B. L., McLean, S., Zhu, X., & Chuang, D. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02444.x · Cited by 66 · see citing works

The Effect of Tryptophan Depletion on Mood in Medication-Free, Former Patients with Major Affective Disorder

Leyton, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00262-x · Cited by 60 · see citing works

Synthesis of some 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain

Bergström, M., Westerberg, G., Kihlberg, T., & Långström, B. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)80003-0 · Cited by 57 · see citing works

Relapse of depression after rapid depletion of tryptophan

Leyton, M., Young, S. N., & Benkelfat, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61726-6 · Cited by 48 · see citing works

Chronic administration of the antidepressants phenelzine, despiramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain

Todd, K. G., McManus, D. J., & Baker, G. B. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02089946 · Cited by 43 · see citing works

Applying Neuroimaging Ligands to Study Major Depressive Disorder

Meyer, J. H. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.007 · Cited by 41 · see citing works

Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites.

Tweedie, D., & Burke, M. D. (1987) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06611-5 · Cited by 32 · see citing works

A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition

O'Regan, D., Kwok, R. P. S., Yu, P. H., Bailey, B. A., Greenshaw, A. J., & Boulton, A. A. (1987) · Psychopharmacology · doi:10.1007/bf00215477 · Cited by 27 · see citing works

Evaluation of single photon transmission for the HRRT

Knoess, C., Rist, J., Michel, C. J., Burbar, Z., Eriksson, L., Panin, V., Byars, L. G., Lenox, M., Wienhard, K., Heiss, W., et al. (2003) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmic.2003.1352258 · Cited by 20 · see citing works

Immune Disturbances in Treatment-Resistant Depression: Modulation by Antidepressive Treatments

Maes, M. H. J., Vandoolaeghe, E., Hunsel, F. V., Bril, T., Demedts, P., Wauters, A., & Neels, H. M. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199703/04)12:2 · Cited by 19 · see citing works

Depression associated with reserpine therapy.

Rh, B. (1956) · PubMed · Cited by 5 · see citing works

Time for united action on depression: a Lancet–World Psychiatric Association Commission

Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104 · see citing works

Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue

Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603 · see citing works

The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology

Belleau, E. L., Treadway, M. T., & Pizzagalli, D. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.031 · Cited by 550 · see citing works

The neurobiology of depression and antidepressant action

Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519 · see citing works

A Treatment-Resistant Default Mode Subnetwork in Major Depression

Li, B., Liu, L., Friston, K. J., Shen, H., Wang, L., Zeng, L.-L., & Hu, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.007 · Cited by 333 · see citing works

Synaptic plasticity in depression: molecular, cellular and functional correlates.

Marsden, W. N. (2013) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 321 · see citing works

An excitatory synapse hypothesis of depression

Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265 · see citing works

Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study

Setiawan, E., Attwells, S., Wilson, A. A., Mizrahi, R., Rusjan, P., Miler, L., Xu, C., Sharma, S. K., Kish, S. J., Houle, S., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30048-8 · Cited by 245 · see citing works

Tranylcypromine in mind (Part I): Review of pharmacology

Ulrich, S., Ricken, R., & Adli, M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.05.007 · Cited by 239 · see citing works

Biological hypotheses and biomarkers of bipolar disorder

Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 247 · see citing works

Distribution of Monoamine Oxidase Proteins in Human Brain: Implications for Brain Imaging Studies

Tong, J., Meyer, J. H., Furukawa, Y., Boileau, I., Chang, L., Wilson, A. A., & Houle, S. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.19 · Cited by 214 · see citing works

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders

Tong, J., Rathitharan, G., Meyer, J. H., Furukawa, Y., Ang, L.-C., Boileau, I., Guttman, M., Hornykiewicz, O., & Kish, S. J. (2017) · Brain · doi:10.1093/brain/awx172 · Cited by 204 · see citing works

Elevated brain monoamine oxidase A binding in the early postpartum period

Sacher, J., Wilson, A. A., Houle, S., Rusjan, P., Hassan, S., Bloomfield, P. M., Stewart, D. E., & Meyer, J. H. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.32 · Cited by 202 · see citing works

Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies

Davis, M. T., Holmes, S. E., Pietrzak, R. H., & Esterlis, I. (2017) · Chronic Stress · doi:10.1177/2470547017710916 · Cited by 176 · see citing works

Neuroreceptor imaging in depression

Savitz, J. B., & Drevets, W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.001 · Cited by 165 · see citing works

The Development, Past Achievements, and Future Directions of Brain PET

Jones, T., & Rabiner, E. (2012) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2012.20 · Cited by 128 · see citing works

Evidence that the methylation state of the monoamine oxidase A (<i><i>MAOA</i></i>) gene predicts brain activity of MAO A enzyme in healthy men

Shumay, E., Logan, J., Volkow, N. D., & Fowler, J. S. (2012) · Epigenetics · doi:10.4161/epi.21976 · Cited by 120 · see citing works

Depression: Biological markers and treatment

Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 120 · see citing works

In Vitro , In Vivo , and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions

Flanagan, S., Bartizal, K. F., Minassian, S. L., Fang, E., & Prokocimer, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00431-13 · Cited by 108 · see citing works

Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression

Grunewald, M. E., Johnson, S., Lu, D., Wang, Z., Lomberk, G. A., Albert, P. R., Stockmeier, C. A., Meyer, J. H., Urrutia, R. A., Miczek, K. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373936 · Cited by 102 · see citing works

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works

Relationship of Monoamine Oxidase-A Distribution Volume to Postpartum Depression and Postpartum Crying

Sacher, J., Rekkas, P. V., Wilson, A. A., Houle, S., Romano, L., Hamidi, J., Rusjan, P., Fan, I., Stewart, D. E., & Meyer, J. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.190 · Cited by 94 · see citing works

Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression

Lum, C. T., & Stahl, S. M. (2012) · CNS Spectrums · doi:10.1017/s1092852912000594 · Cited by 91 · see citing works

Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge

Erritzøe, D., Godlewska, B. R., Rizzo, G., Searle, G. E., Agnorelli, C., Lewis, Y. L., Ashok, A. H., Colasanti, A., Boura, I., Farrell, C. M., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.10.012 · Cited by 90 · see citing works

Monoamine oxidases in major depressive disorder and alcoholism.

Duncan, J. W., Johnson, S., & Ou, X.-M. (2012) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2012.v6.3.112 · Cited by 84 · see citing works

The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder

Johnson, S., Stockmeier, C. A., Meyer, J. H., Austin, M. C., Albert, P. R., Wang, J., May, W. L., Rajkowska, G., Overholser, J. C., Jurjus, G., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.105 · Cited by 85 · see citing works

Greater Monoamine Oxidase A Binding in Perimenopausal Age as Measured With Carbon 11–Labeled Harmine Positron Emission Tomography

Rekkas, P. V., Wilson, A. A., Lee, V. W. H., Yogalingam, P., Sacher, J., Rusjan, P., Houle, S., Stewart, D. E., Kolla, N. J., Kish, S. J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.250 · Cited by 80 · see citing works

Biomarker Approaches in Major Depressive Disorder Evaluated in the Context of Current Hypotheses

Jentsch, M., van Buel, E. M., Bosker, F. J., Gladkevich, A. V., Klein, H. C., Voshaar, R. C. O., Ruhé, H. G., Eisel, U. L., & Schoevers, R. A. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.114 · Cited by 79 · see citing works

Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms

Chiuccariello, L., Houle, S., Miler, L., Cooke, R. G., Rusjan, P., Rajkowska, G., Levitan, R. D., Kish, S. J., Kolla, N. J., Ou, X., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.297 · Cited by 75 · see citing works

Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: A systematic review and network meta-analysis

Suchting, R., Tirumalaraju, V., Gareeb, R., Bockmann, T., de Dios, C., Aickareth, J., Pinjari, O., Soares, J. C., Cowen, P. J., & Selvaraj, S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.021 · Cited by 73 · see citing works

Monoamine Oxidase A Binding in the Prefrontal and Anterior Cingulate Cortices During Acute Withdrawal From Heavy Cigarette Smoking

Bacher, I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.82 · Cited by 71 · see citing works

Zebrafish models of major depressive disorders

Fonseka, T. M., Wen, X., Foster, J. A., & Kennedy, S. H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23639 · Cited by 72 · see citing works

Drugs related to monoamine oxidase activity

Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 72 · see citing works

Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and Prevention

Meyer, J. H. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.285 · Cited by 64 · see citing works

Translational PET imaging research

Hargreaves, R. J., & Rabiner, E. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.017 · Cited by 61 · see citing works

Iron-Restricted Diet Affects Brain Ferritin Levels, Dopamine Metabolism and Cellular Prion Protein in a Region-Specific Manner

Pino, J. M. V., da Luz, M. H. M., Antunes, H. K. M., Giampá, S. Q. D. C., Martins, V. R., & Lee, K. S. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00145 · Cited by 60 · see citing works

Adaptations in reward-related behaviors and mesolimbic dopamine function during motherhood and the postpartum period

Rincón‐Cortés, M., & Grace, A. A. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100839 · Cited by 60 · see citing works

New insights on the antidepressant discontinuation syndrome

Harvey, B. H., & Slabbert, F. N. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2429 · Cited by 61 · see citing works

Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder

Korb, A. S., Hunter, A. M., Cook, I. A., & Leuchter, A. F. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.12.007 · Cited by 59 · see citing works

Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John’s wort: an [11C]-harmine PET study

Sacher, J., Houle, S., Parkes, J., Rusjan, P., Sagrati, S., Wilson, A. A., & Meyer, J. H. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100117 · Cited by 58 · see citing works

The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease

Verma, A., Waiker, D. K., Bhardwaj, B., Saraf, P., & Shrivastava, S. K. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105562 · Cited by 58 · see citing works

A neuroscientific update on monoamine oxidase and its inhibitors

Schwartz, T. L. (2013) · CNS Spectrums · doi:10.1017/s1092852913000734 · Cited by 58 · see citing works

Therapeutic Drug Monitoring for Antidepressant Drug Treatment

Haji, E. O., Hiemke, C., & Pfuhlmann, B. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523699 · Cited by 57 · see citing works

Antidepressant-like effects of water extract of Gastrodia elata Blume in rats exposed to unpredictable chronic mild stress via modulation of monoamine regulatory pathways

Lin, Y., Lin, S.-H., Chen, W.-C., Ho, C., Lai, Y.-S., Panyod, S., & Sheen, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.04.032 · Cited by 57 · see citing works

Regulatory Pathways of Monoamine Oxidase A during Social Stress

Higuchi, Y., Soga, T., & Parhar, I. S. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00604 · Cited by 57 · see citing works

Increased Seasonal Variation in Serotonin Transporter Binding in Seasonal Affective Disorder

Tyrer, A. E., Levitan, R. D., Houle, S., Wilson, A. A., Nóbrega, J. N., & Meyer, J. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.54 · Cited by 56 · see citing works

Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits

Soliman, A., Bagby, R. M., Wilson, A. A., Miler, L., Clark, M., Rusjan, P., Sacher, J., Houle, S., & Meyer, J. H. (2010) · Psychological Medicine · doi:10.1017/s0033291710001601 · Cited by 52 · see citing works

Monoamine Oxidase Inhibitors and Neuroprotection

Al-Nuaimi, S. K., MacKenzie, E. M., & Baker, G. B. (2012) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31825b9eb5 · Cited by 51 · see citing works

Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition

Kolla, N. J., Chiuccariello, L., Wilson, A. A., Houle, S., Links, P. S., Bagby, R. M., McMain, S., Kellow, C., Patel, J., Rekkas, P. V., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.024 · Cited by 47 · see citing works

Low glucocorticoids in stress-related disorders: the role of inflammation

Sarapultsev, A., Sarapultsev, P., Dremencov, E., Komelkova, M. V., Tseilikman, O. B., & Цейликман, В. Э. (2020) · Stress · doi:10.1080/10253890.2020.1766020 · Cited by 47 · see citing works

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants

Eap, C. B., Gründer, G., Baumann, P., Ansermot, N., Conca, A., Corruble, E., Crettol, S., Dahl, M., de León, J., Greiner, C., et al. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1878427 · Cited by 49 · see citing works

Evidence Revealing Deregulation of The KLF11-Mao A Pathway in Association with Chronic Stress and Depressive Disorders

Harris, S., Johnson, S., Duncan, J. W., Udemgba, C., Meyer, J. H., Albert, P. R., Lomberk, G. A., Urrutia, R. A., Ou, X., Stockmeier, C. A., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.321 · Cited by 43 · see citing works

Serotonin transporter binding is reduced in seasonal affective disorder following light therapy

Tyrer, A. E., Levitan, R. D., Houle, S., Wilson, A. A., Nóbrega, J. N., Rusjan, P., & Meyer, J. H. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12632 · Cited by 44 · see citing works

Rapid screening and identification of monoamine oxidase-A inhibitors from Corydalis Rhizome using enzyme-immobilized magnetic beads based method

Zhang, Y., Wang, Q., Liu, R., Zhou, H., Crommen, J., Moaddel, R., Jiang, Z., & Zhang, T. (2019) · Journal of Chromatography A · doi:10.1016/j.chroma.2019.01.062 · Cited by 43 · see citing works

Monoamine Oxidase and Dopamine β-Hydroxylase Inhibitors from the Fruits of Gardenia jasminoides

Kim, J.-H., Kim, G.-H., & Hwang, K.-H. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.2.214 · Cited by 41 · see citing works

Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex

Harrison, S. J., Tyrer, A. E., Levitan, R. D., Xu, X., Houle, S., Wilson, A. A., Nóbrega, J. N., Rusjan, P., & Meyer, J. H. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12424 · Cited by 41 · see citing works

Development of new radiopharmaceuticals for imaging monoamine oxidase B.

Vasdev, N., Sadovski, O., Moran, M. D., Parkes, J., Meyer, J., Houle, S., & Wilson, A. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.03.003 · Cited by 38 · see citing works

Monoamine oxidase and neurodegeneration: Mechanisms, inhibitors and natural compounds for therapeutic intervention

Banerjee, C., Tripathy, D., Kumar, D., & Chakraborty, J. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105831 · Cited by 40 · see citing works

Using positron emission tomography to investigate hormone-mediated neurochemical changes across the female lifespan: implications for depression

Zsido, R. G., Villringer, A., & Sacher, J. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1397607 · Cited by 39 · see citing works

PET radiopharmaceuticals for probing enzymes in the brain.

Holland, J. P., Cumming, P. D., & Vasdev, N. (2013) · Europe PMC (PubMed Central) · Cited by 39 · see citing works

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors

Chiuccariello, L., Cooke, R. G., Miler, L., Levitan, R. D., Baker, G. B., Kish, S. J., Kolla, N. J., Rusjan, P., Houle, S., Wilson, A. A., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv078 · Cited by 36 · see citing works

Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood

Dowlati, Y., Ravindran, A. V., Segal, Z. V., Stewart, D. E., Steiner, M. S., & Meyer, J. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611965114 · Cited by 36 · see citing works

Convergent Effects of Acute Stress and Glucocorticoid Exposure upon MAO-A in Humans

Soliman, A., Udemgba, C., Fan, I., Xu, X. Y., Miler, L., Rusjan, P., Houle, S., Wilson, A. A., Pruessner, J. C., Ou, X., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2091-12.2012 · Cited by 36 · see citing works

Dynamic, Adaptive Changes in MAO-A Binding after Alterations in Substrate Availability: An in vivo [ 11 C]-Harmine Positron Emission Tomography Study

Sacher, J., Rabiner, E. A., Clark, M., Rusjan, P., Soliman, A., Boskovic, R., Kish, S. J., Wilson, A. A., Houle, S., & Meyer, J. H. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.184 · Cited by 33 · see citing works

Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy

Spies, M., James, G. M., Vraka, C., Philippe, C., Hienert, M., Gryglewski, G., Komorowski, A., Kautzky, A., Silberbauer, L., Pichler, V., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0227-2 · Cited by 33 · see citing works

Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K

Kim, J. H., Son, Y. K., Kim, G. H., & Hwang, K. H. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.100 · Cited by 32 · see citing works

Social Defeat Stress Decreases mRNA for Monoamine Oxidase A and Increases 5-HT Turnover in the Brain of Male Nile Tilapia (Oreochromis niloticus)

Higuchi, Y., Soga, T., & Parhar, I. S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01549 · Cited by 31 · see citing works

Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR

Luykx, J. J., Bakker, S. C., van Geloven, N., Eijkemans, M. J. C., Horvath, S., Lentjes, E. G. W. M., Boks, M. P., Strengman, E., DeYoung, J. A., Buizer‐Voskamp, J. E., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.84 · Cited by 31 · see citing works

Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment

Ebrahimi-Ghiri, M., Nasehi, M., & Zarrindast, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.034 · Cited by 31 · see citing works

Neuroprogression and Immune Activation in Major Depressive Disorder

Meyer, J. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470804 · Cited by 30 · see citing works

Phenelzine, a cell adhesion molecule L1 mimetic small organic compound, promotes functional recovery and axonal regrowth in spinal cord-injured zebrafish

Li, R., Sahu, S. S., & Schachner, M. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.05.013 · Cited by 30 · see citing works

The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography

Baldinger, P., Gryglewski, G., Philippe, C., James, G. M., Vraka, C., Silberbauer, L., Balber, T., Vanicek, T., Pichler, V., Unterholzner, J., et al. (2019) · Brain stimulation · doi:10.1016/j.brs.2018.12.976 · Cited by 30 · see citing works

Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells

Liu, W., Rabinovich, A., Nash, Y., Frenkel, D., Wang, Y., Youdim, M. B. H., & Weinreb, O. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.028 · Cited by 30 · see citing works

Apigenin attenuates depressive-like behavior via modulating monoamine oxidase A enzyme activity in chronically stressed mice

Olayinka, J. N., Akawa, O. B., Ogbu, E. K., Eduviere, A. T., Ozolua, R. I., & Soliman, M. E. S. (2023) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2023.100161 · Cited by 28 · see citing works

Greater Monoamine Oxidase A Binding in Alcohol Dependence

Matthews, B. A., Kish, S. J., Xu, X. Y., Boileau, I., Rusjan, P., Wilson, A. A., DiGiacomo, D., Houle, S., & Meyer, J. H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.010 · Cited by 27 · see citing works

Integration of transcriptomic and cytoarchitectonic data implicates a role for MAOA and TAC1 in the limbic-cortical network

Bludau, S., Mühleisen, T. W., Eickhoff, S. B., Hawrylycz, M., Cichon, S., & Amunts, K. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1620-6 · Cited by 27 · see citing works

Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging study

Kolla, N. J., Dunlop, K., Downar, J. H., Links, P. S., Bagby, R. M., Wilson, A. A., Houle, S., Rasquinha, F., Simpson, A. I. F., & Meyer, J. H. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.030 · Cited by 27 · see citing works

Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase

Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 27 · see citing works

Early life environmental and pharmacological stressors result in persistent dysregulations of the serotonergic system

Wong, P., Sze, Y., Gray, L. J. M., Chang, C. C. R., Cai, S., & Zhang, X. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00094 · Cited by 27 · see citing works

Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity

Smith, D. F., & Jakobsen, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00008 · Cited by 25 · see citing works

Barriers to achieving treatment goals: A focus on sleep disturbance and sexual dysfunction

Morehouse, R. L., MacQUEEN, G. M., & Kennedy, S. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.047 · Cited by 24 · see citing works

Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain

Higuchi, Y., Soga, T., & Parhar, I. S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00339 · Cited by 22 · see citing works

Cronobacter sakazakii infection alters serotonin transporter and improved fear memory retention in the rat

Sivamaruthi, B. S., Madhumita, R., Balamurugan, K., & Rajan, K. E. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00188 · Cited by 22 · see citing works

Serotonin Receptor Imaging: Clinically Useful?

Parsey, R. V. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068908 · Cited by 22 · see citing works

Molecular imaging as a guide for the treatment of central nervous system disorders

Kim, E., Howes, O., & Kapur, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/ekim · Cited by 23 · see citing works

Colistin sulphate induced neurotoxicity: Studies on cholinergic, monoaminergic, purinergic and oxidative stress biomarkers

Ajiboye, T. O. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.189 · Cited by 22 · see citing works

Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update

Choudhary, D., Kaur, R., Singh, T. G., & Kumar, B. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266280249240126052505 · Cited by 19 · see citing works

Molecular Imaging for Depressive Disorders

Lee, T. S., Quek, S., & Krishnan, K. R. R. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3965 · Cited by 19 · see citing works

Electroacupuncture improves repeated social defeat stress-elicited social avoidance and anxiety-like behaviors by reducing Lipocalin-2 in the hippocampus

Chen, Y., Xie, S.-Y., Chen, C., & Lu, D. (2021) · Molecular Brain · doi:10.1186/s13041-021-00860-0 · Cited by 19 · see citing works

No effect of oral l-tryptophan or alpha-lactalbumin on total tryptophan levels in breast milk

Dowlati, Y., Ravindran, A. V., Maheux, M., Steiner, M. S., Stewart, D. E., & Meyer, J. H. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.005 · Cited by 18 · see citing works

[11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification

Zanderigo, F., D’Agostino, A. E., Joshi, N., Schain, M., Kumar, D. J. S., Parsey, R. V., DeLorenzo, C., & Mann, J. J. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1165-3 · Cited by 17 · see citing works

Parameter evaluation and fully-automated radiosynthesis of [ 11 C]harmine for imaging of MAO-A for clinical trials

Philippe, C., Zeilinger, M., Mitterhauser, M., Dumanic, M., Lanzenberger, R. R., Hacker, M., & Wadsak, W. (2015) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2015.01.002 · Cited by 17 · see citing works

Predicting a Potential Link to Antidepressant Effect: Neuroprotection of Zhi-zi-chi Decoction on Glutamate-induced Cytotoxicity in PC12 Cells

Zhang⋆, Y., Luo, Y., Zhang, D., Pang, B., Wen, J., & Zhou, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.625108 · Cited by 16 · see citing works

Resting-state mapping of neural signatures of vulnerability to depression relapse

Liu, C., Tang, L., Gao, Y., Zhang, G., Li, B., Li, M., Woelfer, M., Martin, W., & Wang, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.022 · Cited by 17 · see citing works

Sex and the serotonergic underpinnings of depression and migraine

Spies, M., Handschuh, P. A., Lanzenberger, R. R., & Kranz, G. S. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00009-6 · Cited by 16 · see citing works

Abnormal function of monoamine oxidase-A in comorbid major depressive disorder and cardiovascular disease: Pathophysiological and therapeutic implications (Review)

Machado‐Vieira, R. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1062 · Cited by 16 · see citing works

Charting the dorsal-medial functional gradient of the default mode network in major depressive disorder

Xiao, Y., Wang, D., Tan, Z., Hong, L., Wang, Y., Pan, C., Lan, Z., Kuai, C., & Xue, S. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.059 · Cited by 14 · see citing works

Clinical, Research and Treatment Approaches to Affective Disorders

Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 7 · see citing works

Disentangling trait, occasion-specific, and accumulated situational effects of psychological distress in adulthood: evidence from the 1958 and 1970 British birth cohorts

Scarpato, B. S., Swardfager, W., Eid, M., Ploubidis, G. B., & Cogo‐Moreira, H. (2020) · Psychological Medicine · doi:10.1017/s0033291719003805 · Cited by 13 · see citing works

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 13 · see citing works

Brain monoamine oxidase a binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery and recurrence

Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., Clark, M., Sacher, J., Voineskos, A. N., & Houle, S. (2009) · Max Planck Institute for Plasma Physics · Cited by 6 · see citing works

Elevated Monoamine Oxidase A Levels in the Brain: An Explanation for the Monoamine Imbalance of Major Depression

Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585 · see citing works

Brain Serotonin 1A Receptor Binding as a Predictor of Treatment Outcome in Major Depressive Disorder

Miller, J. M., Hesselgrave, N., Ogden, R. T., Zanderigo, F., Oquendo, M. A., Mann, J. J., & Parsey, R. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.021 · Cited by 91 · see citing works

Monoamine Oxidase A in Relation to Subtypes and Treatment of Major Depressive Disorder

Chiuccariello, L. (2015) · TSpace (University of Toronto)

Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms

Chiuccariello, L., Houle, S., Miler, L., Cooke, R. G., Rusjan, P., Rajkowska, G., Levitan, R. D., Kish, S. J., Kolla, N. J., Ou, X., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.297 · Cited by 75 · see citing works